Civica Rx and Xellia Pharmaceuticals Join Forces

Civica Rx announces its first supplier partner, Xellia Pharmaceuticals. Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems to address shortages of these anti-infective medications and improve patient care in hospitals across the US. Today marks the first time that Civica is announcing the production of generic drugs –...

Civica Rx Opens New Headquarters

Civica Rx recently welcomed the local community for the official opening of its new headquarters in Lehi, UT, just outside of Salt Lake City. Joining the Civica team as speakers for the opening ceremony and ribbon cutting were Utah Governor, Gary Herbert; U.S. Congressman Ben McAdams (UT); Intermountain Healthcare CEO, Marc Harrison, MD; University...

Next Steps for Civica Rx

Civica’s MISSION Ensure that essential generic drugs are available and affordable to everyone Civica’s VISION To be a model generic drug company by providing high-quality FDA approved products at affordable prices Civica’s VALUES Safety, Quality, Accessibility, Affordability and Fairness What's Next? Civica expects to bring over 14 hospital-administered generic drugs to hospitals and health...

2018 Reflections: Celebrating 5 “Firsts” for Civica Rx

New not-for-profit company Civica Rx is established by seven hospital systems and 3 charitable foundations (as reported in FORBES) to address a persistent drug shortage problem that has become a national crisis for hospitals and patients. New leadership Civica Rx announces that Dan Liljenquist, SVP and chief strategy officer at Intermountain Healthcare, will serve as chair of the Civica...

Advantages of Civica Rx

Civica Rx was established in 2018 to address a persistent drug shortage problem that has become a national crisis for hospitals and patients. Civica, a mission-driven, not-for-profit, non-stock generic drug company, was founded by leading hospital systems that know first-hand about the impact of the inconsistent, unpredictable, and often unstable market dynamics that lead...

Scroll to top